1. Home
  2. LNAI vs DETX Comparison

LNAI vs DETX Comparison

Compare LNAI & DETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$2.38

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Logo Liberty Defense Holdings Ltd. Common Shares

DETX

Liberty Defense Holdings Ltd. Common Shares

N/A

Current Price

$2.30

Market Cap

14.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
LNAI
DETX
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
14.8M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
LNAI
DETX
Price
$2.38
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.4K
30.8K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$1.91
52 Week High
$5.02
$4.25

Technical Indicators

Market Signals
Indicator
LNAI
DETX
Relative Strength Index (RSI) 57.10 31.90
Support Level $2.00 $1.91
Resistance Level $3.09 $4.07
Average True Range (ATR) 0.19 0.42
MACD 0.05 -0.14
Stochastic Oscillator 56.69 22.01

Price Performance

Historical Comparison
LNAI
DETX

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

About DETX Liberty Defense Holdings Ltd. Common Shares

Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: